Ledger.Open graph →
SEC Form D · filed August 18, 2020

Taysha Gene Therapies, Inc

Offering
$96.0M
Sold
$96.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Sean A. Nolan · Dallas, TXDirectorPaul B. Manning · Dallas, TXDirectorSukumar B. Nagendran · Dallas, TXDirectorR. A. Session Ii · Dallas, TXExec · DirectorSteve A. Cobb · Carmel, INDirectorElizabeth Zuchelkowski · Detroit, MIDirectorSuyash B. Prasad · Dallas, TXExecKamran B. Alam · Dallas, TXExecLaura Witt · PARK CITY, UTDirectorTodd Forrest · PARK CITY, UTDirectorSukumar B. Nagendran · Dallas, TXDirectorSuyash B. Prasad · Dallas, TXExecKamran B. Alam · Dallas, TXExecR. A. Session Ii · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗